Patients n | 371 |
Age years | 67 (55–77) |
Men | 189 (50.9) |
NTM-pulmonary disease | 260 (70.1) |
Nodular-bronchiectatic type | 137 (36.9) |
Fibro-cavitary type | 14 (3.8) |
Mixed or other type | 109 (29.3) |
Underlying lung diseases | 183 (49.3) |
Bronchiectasis | 131 (35.3) |
Chronic obstructive pulmonary disease | 57 (15.4) |
Remote history of pulmonary tuberculosis | 58 (15.6) |
Interstitial lung disease | 3 (0.8) |
Pneumoconioses | 1 (0.3) |
Diabetes mellitus | 72 (19.4) |
Congestive heart failure | 39 (10.5) |
Chronic kidney disease stage IV–V | 26 (7.0) |
Chronic hepatitis B | 28 (7.5) |
Chronic hepatitis C | 11 (3.0) |
Autoimmune disease | 18 (4.9) |
Anti-interferon-γ autoantibodies | 9 (2.4) |
Anti-GM-CSF autoantibodies | 1 (0.3) |
Gastro-oesophageal reflux disease | 43 (11.6) |
Human immunodeficiency virus infection | 1 (0.3) |
Haematological/bone marrow transplantation | 5 (1.3) |
Solid organ transplantation | 3 (0.8) |
Thyroid disease | 22 (5.9) |
Neurological disease | 76 (20.5) |
Malignancy | 89 (24.0) |
Head and neck cancer | 22 (5.9) |
Upper gastrointestinal cancer | 16 (4.4) |
Lung cancer | 13 (3.5) |
Renal, bladder and prostate cancer | 11 (3.0) |
Colorectal cancer | 9 (2.4) |
Breast cancer | 9 (2.4) |
Haematological | 5 (1.3) |
Neuroendocrine | 3 (0.8) |
Other | 4 (1.1) |
Deaths during follow-up | 113 (30.5) |
In-hospital deaths | 66 (17.8) |
Cause of death: sepsis (including pneumonia) | 34 (9.2) |
Cause of death: pneumonia | 30 (8.1) |
Cause of death: NTM-PD | 5 (1.3) |
Cause of death: cancer | 6 (1.6) |
Cause of death: haemorrhage | 4 (1.1) |
Duration of follow-up years | 2.8±8.7 |